Exact Mass: 846.7676

TG(14:0/15:0/22:1(13Z))

C54H102O6 (846.7676)

TG(14:0/15:0/22:1(13Z)) is a monoerucic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(14:0/15:0/22:1(13Z)), in particular, consists of one chain of myristic acid at the C-1 position, one chain of pentadecanoic acid at the C-2 position and one chain of erucic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(14:0/20:1(11Z)/O-18:0)

C55H106O5 (846.804)

TG(14:0/20:1(11Z)/O-18:0) is a monoeicosenoic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(14:0/20:1(11Z)/O-18:0), in particular, consists of one chain of myristic acid at the C-1 position, one chain of eicosenoic acid at the C-2 position and one chain of Stearyl alcohol at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(14:0/22:1(13Z)/15:0)

C54H102O6 (846.7676)

TG(14:0/22:1(13Z)/15:0) is a monoerucic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(14:0/22:1(13Z)/15:0), in particular, consists of one chain of myristic acid at the C-1 position, one chain of erucic acid at the C-2 position and one chain of pentadecanoic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(14:0/O-18:0/20:1(11Z))

C55H106O5 (846.804)

TG(14:0/O-18:0/20:1(11Z)) is a monoeicosenoic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(14:0/O-18:0/20:1(11Z)), in particular, consists of one chain of myristic acid at the C-1 position, one chain of Stearyl alcohol at the C-2 position and one chain of eicosenoic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(15:0/14:0/22:1(13Z))

C54H102O6 (846.7676)

TG(15:0/14:0/22:1(13Z)) is a monoerucic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(15:0/14:0/22:1(13Z)), in particular, consists of one chain of pentadecanoic acid at the C-1 position, one chain of myristic acid at the C-2 position and one chain of erucic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(15:0/16:0/20:1(11Z))

C54H102O6 (846.7676)

TG(15:0/16:0/20:1(11Z)) is a monoeicosenoic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(15:0/16:0/20:1(11Z)), in particular, consists of one chain of pentadecanoic acid at the C-1 position, one chain of palmitic acid at the C-2 position and one chain of eicosenoic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(15:0/18:0/18:1(11Z))

C54H102O6 (846.7676)

TG(15:0/18:0/18:1(11Z)) is a monostearic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(15:0/18:0/18:1(11Z)), in particular, consists of one chain of pentadecanoic acid at the C-1 position, one chain of stearic acid at the C-2 position and one chain of vaccenic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(15:0/18:0/18:1(9Z))

C54H102O6 (846.7676)

TG(15:0/18:0/18:1(9Z)) is a monostearic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(15:0/18:0/18:1(9Z)), in particular, consists of one chain of pentadecanoic acid at the C-1 position, one chain of stearic acid at the C-2 position and one chain of oleic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(15:0/20:0/16:1(9Z))

C54H102O6 (846.7676)

TG(15:0/20:0/16:1(9Z)) is a monoarachidic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(15:0/20:0/16:1(9Z)), in particular, consists of one chain of pentadecanoic acid at the C-1 position, one chain of arachidic acid at the C-2 position and one chain of palmitoleic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(15:0/22:0/14:1(9Z))

C54H102O6 (846.7676)

TG(15:0/22:0/14:1(9Z)) is a monobehenic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(15:0/22:0/14:1(9Z)), in particular, consists of one chain of pentadecanoic acid at the C-1 position, one chain of behenic acid at the C-2 position and one chain of myristoleic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(15:0/14:1(9Z)/22:0)

C54H102O6 (846.7676)

TG(15:0/14:1(9Z)/22:0) is a monobehenic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(15:0/14:1(9Z)/22:0), in particular, consists of one chain of pentadecanoic acid at the C-1 position, one chain of myristoleic acid at the C-2 position and one chain of behenic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(15:0/16:1(9Z)/20:0)

C54H102O6 (846.7676)

TG(15:0/16:1(9Z)/20:0) is a monoarachidic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(15:0/16:1(9Z)/20:0), in particular, consists of one chain of pentadecanoic acid at the C-1 position, one chain of palmitoleic acid at the C-2 position and one chain of arachidic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(15:0/18:1(11Z)/18:0)

C54H102O6 (846.7676)

TG(15:0/18:1(11Z)/18:0) is a monovaccenic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(15:0/18:1(11Z)/18:0), in particular, consists of one chain of pentadecanoic acid at the C-1 position, one chain of vaccenic acid at the C-2 position and one chain of stearic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(15:0/18:1(9Z)/18:0)

C54H102O6 (846.7676)

TG(15:0/18:1(9Z)/18:0) is a monooleic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(15:0/18:1(9Z)/18:0), in particular, consists of one chain of pentadecanoic acid at the C-1 position, one chain of oleic acid at the C-2 position and one chain of stearic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(15:0/20:1(11Z)/16:0)

C54H102O6 (846.7676)

TG(15:0/20:1(11Z)/16:0) is a monoeicosenoic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(15:0/20:1(11Z)/16:0), in particular, consists of one chain of pentadecanoic acid at the C-1 position, one chain of eicosenoic acid at the C-2 position and one chain of palmitic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(16:0/15:0/20:1(11Z))

C54H102O6 (846.7676)

TG(16:0/15:0/20:1(11Z)) is a monoeicosenoic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(16:0/15:0/20:1(11Z)), in particular, consists of one chain of palmitic acid at the C-1 position, one chain of pentadecanoic acid at the C-2 position and one chain of eicosenoic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(16:0/18:1(11Z)/O-18:0)

C55H106O5 (846.804)

TG(16:0/18:1(11Z)/O-18:0) is a monovaccenic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(16:0/18:1(11Z)/O-18:0), in particular, consists of one chain of palmitic acid at the C-1 position, one chain of vaccenic acid at the C-2 position and one chain of Stearyl alcohol at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(16:0/18:1(9Z)/O-18:0)

C55H106O5 (846.804)

TG(16:0/18:1(9Z)/O-18:0) is a monooleic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(16:0/18:1(9Z)/O-18:0), in particular, consists of one chain of palmitic acid at the C-1 position, one chain of oleic acid at the C-2 position and one chain of Stearyl alcohol at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(16:0/O-18:0/18:1(11Z))

C55H106O5 (846.804)

TG(16:0/O-18:0/18:1(11Z)) is a monoStearyl alcohol triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(16:0/O-18:0/18:1(11Z)), in particular, consists of one chain of palmitic acid at the C-1 position, one chain of Stearyl alcohol at the C-2 position and one chain of vaccenic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(16:0/O-18:0/18:1(9Z))

C55H106O5 (846.804)

TG(16:0/O-18:0/18:1(9Z)) is a monoStearyl alcohol triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(16:0/O-18:0/18:1(9Z)), in particular, consists of one chain of palmitic acid at the C-1 position, one chain of Stearyl alcohol at the C-2 position and one chain of oleic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(18:0/15:0/18:1(11Z))

C54H102O6 (846.7676)

TG(18:0/15:0/18:1(11Z)) is a monostearic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(18:0/15:0/18:1(11Z)), in particular, consists of one chain of stearic acid at the C-1 position, one chain of pentadecanoic acid at the C-2 position and one chain of vaccenic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(18:0/15:0/18:1(9Z))

C54H102O6 (846.7676)

TG(18:0/15:0/18:1(9Z)) is a monostearic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(18:0/15:0/18:1(9Z)), in particular, consists of one chain of stearic acid at the C-1 position, one chain of pentadecanoic acid at the C-2 position and one chain of oleic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(18:0/16:1(9Z)/O-18:0)

C55H106O5 (846.804)

TG(18:0/16:1(9Z)/O-18:0) is a monostearic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(18:0/16:1(9Z)/O-18:0), in particular, consists of one chain of stearic acid at the C-1 position, one chain of palmitoleic acid at the C-2 position and one chain of Stearyl alcohol at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(18:0/O-18:0/16:1(9Z))

C55H106O5 (846.804)

TG(18:0/O-18:0/16:1(9Z)) is a monostearic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(18:0/O-18:0/16:1(9Z)), in particular, consists of one chain of stearic acid at the C-1 position, one chain of Stearyl alcohol at the C-2 position and one chain of palmitoleic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(20:0/15:0/16:1(9Z))

C54H102O6 (846.7676)

TG(20:0/15:0/16:1(9Z)) is a monoarachidic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(20:0/15:0/16:1(9Z)), in particular, consists of one chain of arachidic acid at the C-1 position, one chain of pentadecanoic acid at the C-2 position and one chain of palmitoleic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(20:0/14:1(9Z)/O-18:0)

C55H106O5 (846.804)

TG(20:0/14:1(9Z)/O-18:0) is a monoarachidic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(20:0/14:1(9Z)/O-18:0), in particular, consists of one chain of arachidic acid at the C-1 position, one chain of myristoleic acid at the C-2 position and one chain of Stearyl alcohol at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(20:0/O-18:0/14:1(9Z))

C55H106O5 (846.804)

TG(20:0/O-18:0/14:1(9Z)) is a monoarachidic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(20:0/O-18:0/14:1(9Z)), in particular, consists of one chain of arachidic acid at the C-1 position, one chain of Stearyl alcohol at the C-2 position and one chain of myristoleic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(22:0/15:0/14:1(9Z))

C54H102O6 (846.7676)

TG(22:0/15:0/14:1(9Z)) is a monobehenic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(22:0/15:0/14:1(9Z)), in particular, consists of one chain of behenic acid at the C-1 position, one chain of pentadecanoic acid at the C-2 position and one chain of myristoleic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(14:1(9Z)/20:0/O-18:0)

C55H106O5 (846.804)

TG(14:1(9Z)/20:0/O-18:0) is a monoarachidic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(14:1(9Z)/20:0/O-18:0), in particular, consists of one chain of myristoleic acid at the C-1 position, one chain of arachidic acid at the C-2 position and one chain of Stearyl alcohol at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(16:1(9Z)/18:0/O-18:0)

C55H106O5 (846.804)

TG(16:1(9Z)/18:0/O-18:0) is a monostearic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(16:1(9Z)/18:0/O-18:0), in particular, consists of one chain of palmitoleic acid at the C-1 position, one chain of stearic acid at the C-2 position and one chain of Stearyl alcohol at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(18:1(11Z)/16:0/O-18:0)

C55H106O5 (846.804)

TG(18:1(11Z)/16:0/O-18:0) is a monovaccenic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(18:1(11Z)/16:0/O-18:0), in particular, consists of one chain of vaccenic acid at the C-1 position, one chain of palmitic acid at the C-2 position and one chain of Stearyl alcohol at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(18:1(9Z)/16:0/O-18:0)

C55H106O5 (846.804)

TG(18:1(9Z)/16:0/O-18:0) is a monooleic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(18:1(9Z)/16:0/O-18:0), in particular, consists of one chain of oleic acid at the C-1 position, one chain of palmitic acid at the C-2 position and one chain of Stearyl alcohol at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(20:1(11Z)/14:0/O-18:0)

C55H106O5 (846.804)

TG(20:1(11Z)/14:0/O-18:0) is a monoeicosenoic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(20:1(11Z)/14:0/O-18:0), in particular, consists of one chain of eicosenoic acid at the C-1 position, one chain of myristic acid at the C-2 position and one chain of Stearyl alcohol at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

ursa-12-ene-11-one-3-ol octacosanate

C58H102O3 (846.7829)

TG(14:0/15:0/22:1(11Z))[iso6]

C54H102O6 (846.7676)

TG(14:0/15:1(9Z)/22:0)[iso6]

C54H102O6 (846.7676)

TG(14:0/16:1(9Z)/21:0)[iso6]

C54H102O6 (846.7676)

TG(14:0/17:0/20:1(11Z))[iso6]

C54H102O6 (846.7676)

TG(14:0/17:1(9Z)/20:0)[iso6]

C54H102O6 (846.7676)

TG(14:0/18:0/19:1(9Z))[iso6]

C54H102O6 (846.7676)

TG(14:0/18:1(9Z)/19:0)[iso6]

C54H102O6 (846.7676)

TG(14:1(9Z)/15:0/22:0)[iso6]

C54H102O6 (846.7676)

TG(14:1(9Z)/16:0/21:0)[iso6]

C54H102O6 (846.7676)

TG(14:1(9Z)/17:0/20:0)[iso6]

C54H102O6 (846.7676)

TG(14:1(9Z)/18:0/19:0)[iso6]

C54H102O6 (846.7676)

TG(15:0/15:1(9Z)/21:0)[iso6]

C54H102O6 (846.7676)

TG(15:0/16:0/20:1(11Z))[iso6]

C54H102O6 (846.7676)

TG(15:0/16:1(9Z)/20:0)[iso6]

C54H102O6 (846.7676)

TG(15:0/17:0/19:1(9Z))[iso6]

C54H102O6 (846.7676)

TG(15:0/17:1(9Z)/19:0)[iso6]

C54H102O6 (846.7676)

TG(15:0/18:0/18:1(9Z))[iso6]

C54H102O6 (846.7676)

TG(15:1(9Z)/16:0/20:0)[iso6]

C54H102O6 (846.7676)

TG(15:1(9Z)/17:0/19:0)[iso6]

C54H102O6 (846.7676)

TG(17:0/17:0/17:1)[iso3]

C54H102O6 (846.7676)

TG(16:0/17:1/18:0)[iso6]

C54H102O6 (846.7676)

TG(16:1/17:0/18:0)[iso6]

C54H102O6 (846.7676)

TG(16:0/17:0/18:1)[iso6]

C54H102O6 (846.7676)

TG(16:0/16:1/19:0)[iso6]

C54H102O6 (846.7676)

TG(15:1(9Z)/18:0/18:0)[iso3]

C54H102O6 (846.7676)

TG(16:0/16:0/19:1(9Z))[iso3]

C54H102O6 (846.7676)

TG(12:0/17:0/22:1(11Z))[iso6]

C54H102O6 (846.7676)

TG(12:0/17:1(9Z)/22:0)[iso6]

C54H102O6 (846.7676)

TG(12:0/18:1(9Z)/21:0)[iso6]

C54H102O6 (846.7676)

TG(12:0/19:0/20:1(11Z))[iso6]

C54H102O6 (846.7676)

TG(12:0/19:1(9Z)/20:0)[iso6]

C54H102O6 (846.7676)

TG(13:0/16:0/22:1(11Z))[iso6]

C54H102O6 (846.7676)

TG(13:0/16:1(9Z)/22:0)[iso6]

C54H102O6 (846.7676)

TG(13:0/17:1(9Z)/21:0)[iso6]

C54H102O6 (846.7676)

TG(13:0/18:0/20:1(11Z))[iso6]

C54H102O6 (846.7676)

TG(13:0/18:1(9Z)/20:0)[iso6]

C54H102O6 (846.7676)

TG(13:0/19:0/19:1(9Z))[iso6]

C54H102O6 (846.7676)

TG 51:1

C54H102O6 (846.7676)

1-Eicosenoyl-2-myristoyl-3-stearyl-glycerol

C55H106O5 (846.804)

N-hexacosanoyl-4-hydroxy-15-methylhexadecasphinganine-1-phosphocholine

C48H99N2O7P (846.719)

2-[[(2R)-2-henicosanoyloxy-3-icosoxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C49H101NO7P+ (846.7315)

2-[[(2R)-2-docosanoyloxy-3-nonadecoxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C49H101NO7P+ (846.7315)

NAOrn 24:0/24:1

C53H102N2O5 (846.7788)

NAOrn 26:1/22:0

C53H102N2O5 (846.7788)

NAOrn 24:1/24:0

C53H102N2O5 (846.7788)

NAOrn 26:0/22:1

C53H102N2O5 (846.7788)

NAOrn 22:1/26:0

C53H102N2O5 (846.7788)

NAOrn 22:0/26:1

C53H102N2O5 (846.7788)

[3,4-Dihydroxy-2-(pentacosanoylamino)octadecyl] 2-(trimethylazaniumyl)ethyl phosphate

C48H99N2O7P (846.719)

PE-Cer 21:0;2O/25:0;O

C48H99N2O7P (846.719)

PE-Cer 20:0;2O/26:0;O

C48H99N2O7P (846.719)

PE-Cer 23:0;2O/23:0;O

C48H99N2O7P (846.719)

PE-Cer 22:0;2O/24:0;O

C48H99N2O7P (846.719)

PE-Cer 26:0;2O/20:0;O

C48H99N2O7P (846.719)

PE-Cer 25:0;2O/21:0;O

C48H99N2O7P (846.719)

PE-Cer 24:0;2O/22:0;O

C48H99N2O7P (846.719)

[1-hydroxy-3-[(16Z,19Z,22Z,25Z)-octacosa-16,19,22,25-tetraenoxy]propan-2-yl] (14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoate

C57H98O4 (846.7465)

[1-hydroxy-3-[(10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-10,13,16,19,22,25-hexaenoxy]propan-2-yl] (15Z,18Z)-hexacosa-15,18-dienoate

C57H98O4 (846.7465)

[1-hydroxy-3-[(14Z,17Z,20Z)-octacosa-14,17,20-trienoxy]propan-2-yl] (11Z,14Z,17Z,20Z,23Z)-hexacosa-11,14,17,20,23-pentaenoate

C57H98O4 (846.7465)

[1-[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoxy]-3-hydroxypropan-2-yl] (13Z,16Z,19Z,22Z,25Z)-octacosa-13,16,19,22,25-pentaenoate

C57H98O4 (846.7465)

[1-[(11Z,14Z,17Z,20Z,23Z)-hexacosa-11,14,17,20,23-pentaenoxy]-3-hydroxypropan-2-yl] (14Z,17Z,20Z)-octacosa-14,17,20-trienoate

C57H98O4 (846.7465)

[1-hydroxy-3-[(17Z,20Z)-octacosa-17,20-dienoxy]propan-2-yl] (8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-8,11,14,17,20,23-hexaenoate

C57H98O4 (846.7465)

[1-[(5Z,8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-5,8,11,14,17,20,23-heptaenoxy]-3-hydroxypropan-2-yl] (Z)-octacos-17-enoate

C57H98O4 (846.7465)

[1-[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoxy]-3-hydroxypropan-2-yl] (16Z,19Z,22Z,25Z)-octacosa-16,19,22,25-tetraenoate

C57H98O4 (846.7465)

[1-[(15Z,18Z)-hexacosa-15,18-dienoxy]-3-hydroxypropan-2-yl] (10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-10,13,16,19,22,25-hexaenoate

C57H98O4 (846.7465)

[1-[(Z)-hexacos-15-enoxy]-3-hydroxypropan-2-yl] (7Z,10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-7,10,13,16,19,22,25-heptaenoate

C57H98O4 (846.7465)

[1-[(8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-8,11,14,17,20,23-hexaenoxy]-3-hydroxypropan-2-yl] (17Z,20Z)-octacosa-17,20-dienoate

C57H98O4 (846.7465)

[1-hydroxy-3-[(Z)-octacos-17-enoxy]propan-2-yl] (5Z,8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-5,8,11,14,17,20,23-heptaenoate

C57H98O4 (846.7465)

[1-hydroxy-3-[(13Z,16Z,19Z,22Z,25Z)-octacosa-13,16,19,22,25-pentaenoxy]propan-2-yl] (12Z,15Z,18Z)-hexacosa-12,15,18-trienoate

C57H98O4 (846.7465)

[1-hydroxy-3-[(7Z,10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-7,10,13,16,19,22,25-heptaenoxy]propan-2-yl] (Z)-hexacos-15-enoate

C57H98O4 (846.7465)

(1-hydroxy-3-octanoyloxypropan-2-yl) (Z)-tetratetracont-33-enoate

C55H106O5 (846.804)

[3-hydroxy-2-[(Z)-icos-11-enoyl]oxypropyl] dotriacontanoate

C55H106O5 (846.804)

(1-hydroxy-3-tetradecanoyloxypropan-2-yl) (Z)-octatriacont-27-enoate

C55H106O5 (846.804)

(1-hydroxy-3-icosanoyloxypropan-2-yl) (Z)-dotriacont-21-enoate

C55H106O5 (846.804)

[3-hydroxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] octatriacontanoate

C55H106O5 (846.804)

[2-[(Z)-heptadec-9-enoyl]oxy-3-hydroxypropyl] pentatriacontanoate

C55H106O5 (846.804)

(1-hydroxy-3-tetracosanoyloxypropan-2-yl) (Z)-octacos-17-enoate

C55H106O5 (846.804)

[3-hydroxy-2-[(Z)-octadec-9-enoyl]oxypropyl] tetratriacontanoate

C55H106O5 (846.804)

[3-hydroxy-2-[(Z)-tridec-9-enoyl]oxypropyl] nonatriacontanoate

C55H106O5 (846.804)

[2-[(Z)-hexadec-9-enoyl]oxy-3-hydroxypropyl] hexatriacontanoate

C55H106O5 (846.804)

[2-[(Z)-docos-13-enoyl]oxy-3-hydroxypropyl] triacontanoate

C55H106O5 (846.804)

[3-hydroxy-2-[(Z)-pentadec-9-enoyl]oxypropyl] heptatriacontanoate

C55H106O5 (846.804)

[2-[(Z)-henicos-11-enoyl]oxy-3-hydroxypropyl] hentriacontanoate

C55H106O5 (846.804)

(1-decanoyloxy-3-hydroxypropan-2-yl) (Z)-dotetracont-31-enoate

C55H106O5 (846.804)

(1-docosanoyloxy-3-hydroxypropan-2-yl) (Z)-triacont-19-enoate

C55H106O5 (846.804)

(1-dodecanoyloxy-3-hydroxypropan-2-yl) (Z)-tetracont-29-enoate

C55H106O5 (846.804)

[3-hydroxy-2-[(Z)-nonadec-9-enoyl]oxypropyl] tritriacontanoate

C55H106O5 (846.804)

(1-hexadecanoyloxy-3-hydroxypropan-2-yl) (Z)-hexatriacont-25-enoate

C55H106O5 (846.804)

[3-hydroxy-2-[(Z)-tetracos-13-enoyl]oxypropyl] octacosanoate

C55H106O5 (846.804)

(1-hydroxy-3-octadecanoyloxypropan-2-yl) (Z)-tetratriacont-23-enoate

C55H106O5 (846.804)

(2-nonanoyloxy-3-octanoyloxypropyl) (Z)-tetratriacont-23-enoate

C54H102O6 (846.7676)

[1-[(Z)-docos-13-enoyl]oxy-3-octoxypropan-2-yl] docosanoate

C55H106O5 (846.804)

(3-docosoxy-2-octanoyloxypropyl) (Z)-docos-13-enoate

C55H106O5 (846.804)

[3-[(Z)-docos-13-enoxy]-2-octanoyloxypropyl] docosanoate

C55H106O5 (846.804)

(3-hexadecoxy-2-tetradecanoyloxypropyl) (Z)-docos-13-enoate

C55H106O5 (846.804)

[2-[(Z)-nonadec-9-enoyl]oxy-3-nonanoyloxypropyl] tricosanoate

C54H102O6 (846.7676)

[3-nonanoyloxy-2-[(Z)-pentadec-9-enoyl]oxypropyl] heptacosanoate

C54H102O6 (846.7676)

[2-decanoyloxy-3-[(Z)-docos-13-enoxy]propyl] icosanoate

C55H106O5 (846.804)

[2-[(Z)-henicos-11-enoyl]oxy-3-octanoyloxypropyl] docosanoate

C54H102O6 (846.7676)

[2-hexadecanoyloxy-3-[(Z)-octadec-9-enoxy]propyl] octadecanoate

C55H106O5 (846.804)

(2-dodecanoyloxy-3-octadecoxypropyl) (Z)-docos-13-enoate

C55H106O5 (846.804)

[3-nonanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] octacosanoate

C54H102O6 (846.7676)

(3-nonanoyloxy-2-octadecanoyloxypropyl) (Z)-tetracos-13-enoate

C54H102O6 (846.7676)

[2-[(Z)-icos-11-enoyl]oxy-3-nonanoyloxypropyl] docosanoate

C54H102O6 (846.7676)

[3-octanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropyl] triacontanoate

C54H102O6 (846.7676)

[2-[(Z)-icos-11-enoyl]oxy-3-octanoyloxypropyl] tricosanoate

C54H102O6 (846.7676)

(3-octadecoxy-2-tetradecanoyloxypropyl) (Z)-icos-11-enoate

C55H106O5 (846.804)

[2-[(Z)-hexadec-9-enoyl]oxy-3-octadecoxypropyl] octadecanoate

C55H106O5 (846.804)

[3-nonanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropyl] nonacosanoate

C54H102O6 (846.7676)

(2-dodecanoyloxy-3-nonanoyloxypropyl) (Z)-triacont-19-enoate

C54H102O6 (846.7676)

[2-decanoyloxy-3-[(Z)-icos-11-enoxy]propyl] docosanoate

C55H106O5 (846.804)

[2-hexadecanoyloxy-3-[(Z)-hexadec-9-enoxy]propyl] icosanoate

C55H106O5 (846.804)

(2-hexadecanoyloxy-3-nonanoyloxypropyl) (Z)-hexacos-15-enoate

C54H102O6 (846.7676)

[3-[(Z)-docos-13-enoxy]-2-tetradecanoyloxypropyl] hexadecanoate

C55H106O5 (846.804)

[2-dodecanoyloxy-3-[(Z)-icos-11-enoxy]propyl] icosanoate

C55H106O5 (846.804)

(3-docosoxy-2-dodecanoyloxypropyl) (Z)-octadec-9-enoate

C55H106O5 (846.804)

[3-[(Z)-octadec-9-enoxy]-2-tetradecanoyloxypropyl] icosanoate

C55H106O5 (846.804)

(2-hexadecanoyloxy-3-hexadecoxypropyl) (Z)-icos-11-enoate

C55H106O5 (846.804)

[2-[(Z)-nonadec-9-enoyl]oxy-3-octanoyloxypropyl] tetracosanoate

C54H102O6 (846.7676)

[3-[(Z)-docos-13-enoxy]-2-dodecanoyloxypropyl] octadecanoate

C55H106O5 (846.804)

(2-octadecanoyloxy-3-tetradecoxypropyl) (Z)-icos-11-enoate

C55H106O5 (846.804)

(3-dodecoxy-2-octadecanoyloxypropyl) (Z)-docos-13-enoate

C55H106O5 (846.804)

[2-[(Z)-hexadec-9-enoyl]oxy-3-tetradecoxypropyl] docosanoate

C55H106O5 (846.804)

[2-[(Z)-heptadec-9-enoyl]oxy-3-nonanoyloxypropyl] pentacosanoate

C54H102O6 (846.7676)

[3-[(Z)-hexadec-9-enoxy]-2-tetradecanoyloxypropyl] docosanoate

C55H106O5 (846.804)

[3-[(Z)-icos-11-enoxy]-2-tetradecanoyloxypropyl] octadecanoate

C55H106O5 (846.804)

[1-[(Z)-henicos-11-enoyl]oxy-3-nonanoyloxypropan-2-yl] henicosanoate

C54H102O6 (846.7676)

[3-nonanoyloxy-2-[(Z)-octadec-9-enoyl]oxypropyl] tetracosanoate

C54H102O6 (846.7676)

[3-dodecoxy-2-[(Z)-octadec-9-enoyl]oxypropyl] docosanoate

C55H106O5 (846.804)

(2-icosanoyloxy-3-nonanoyloxypropyl) (Z)-docos-13-enoate

C54H102O6 (846.7676)

(2-decanoyloxy-3-icosoxypropyl) (Z)-docos-13-enoate

C55H106O5 (846.804)

[2-[(Z)-hexadec-9-enoyl]oxy-3-octanoyloxypropyl] heptacosanoate

C54H102O6 (846.7676)

[2-[(Z)-octadec-9-enoyl]oxy-3-tetradecoxypropyl] icosanoate

C55H106O5 (846.804)

(2-hexadecanoyloxy-3-octadecoxypropyl) (Z)-octadec-9-enoate

C55H106O5 (846.804)

[2-octadecanoyloxy-3-[(Z)-tetradec-9-enoxy]propyl] icosanoate

C55H106O5 (846.804)

[3-icosoxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] octadecanoate

C55H106O5 (846.804)

(2-nonadecanoyloxy-3-octanoyloxypropyl) (Z)-tetracos-13-enoate

C54H102O6 (846.7676)

[1-dodecoxy-3-[(Z)-icos-11-enoyl]oxypropan-2-yl] icosanoate

C55H106O5 (846.804)

(2-decanoyloxy-3-docosoxypropyl) (Z)-icos-11-enoate

C55H106O5 (846.804)

[2-[(Z)-hexadec-9-enoyl]oxy-3-nonanoyloxypropyl] hexacosanoate

C54H102O6 (846.7676)

(2-decanoyloxy-3-nonanoyloxypropyl) (Z)-dotriacont-21-enoate

C54H102O6 (846.7676)

(2-heptadecanoyloxy-3-octanoyloxypropyl) (Z)-hexacos-15-enoate

C54H102O6 (846.7676)

[2-hexadecanoyloxy-3-[(Z)-icos-11-enoxy]propyl] hexadecanoate

C55H106O5 (846.804)

[2-[(Z)-heptadec-9-enoyl]oxy-3-octanoyloxypropyl] hexacosanoate

C54H102O6 (846.7676)

[3-decoxy-2-[(Z)-icos-11-enoyl]oxypropyl] docosanoate

C55H106O5 (846.804)

(3-icosoxy-2-tetradecanoyloxypropyl) (Z)-octadec-9-enoate

C55H106O5 (846.804)

[1-[(Z)-hexadec-9-enoyl]oxy-3-icosoxypropan-2-yl] hexadecanoate

C55H106O5 (846.804)

(2-henicosanoyloxy-3-octanoyloxypropyl) (Z)-docos-13-enoate

C54H102O6 (846.7676)

[3-octadecoxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] icosanoate

C55H106O5 (846.804)

[3-octanoyloxy-2-[(Z)-pentadec-9-enoyl]oxypropyl] octacosanoate

C54H102O6 (846.7676)

[3-hexadecoxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] docosanoate

C55H106O5 (846.804)

[3-[(Z)-hexadec-9-enoxy]-2-octadecanoyloxypropyl] octadecanoate

C55H106O5 (846.804)

[2-dodecanoyloxy-3-[(Z)-octadec-9-enoxy]propyl] docosanoate

C55H106O5 (846.804)

(3-octanoyloxy-2-tridecanoyloxypropyl) (Z)-triacont-19-enoate

C54H102O6 (846.7676)

(2-dodecanoyloxy-3-icosoxypropyl) (Z)-icos-11-enoate

C55H106O5 (846.804)

[2-[(Z)-hexadec-9-enoyl]oxy-3-hexadecoxypropyl] icosanoate

C55H106O5 (846.804)

[3-docosoxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] hexadecanoate

C55H106O5 (846.804)

(2-hexadecanoyloxy-3-tetradecoxypropyl) (Z)-docos-13-enoate

C55H106O5 (846.804)

[1-hexadecoxy-3-[(Z)-octadec-9-enoyl]oxypropan-2-yl] octadecanoate

C55H106O5 (846.804)

(3-octanoyloxy-2-pentadecanoyloxypropyl) (Z)-octacos-17-enoate

C54H102O6 (846.7676)

(3-nonanoyloxy-2-tetradecanoyloxypropyl) (Z)-octacos-17-enoate

C54H102O6 (846.7676)

[3-octanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] nonacosanoate

C54H102O6 (846.7676)

(3-docosoxy-2-tetradecanoyloxypropyl) (Z)-hexadec-9-enoate

C55H106O5 (846.804)

[2-[(Z)-octadec-9-enoyl]oxy-3-octanoyloxypropyl] pentacosanoate

C54H102O6 (846.7676)

(3-decoxy-2-icosanoyloxypropyl) (Z)-docos-13-enoate

C55H106O5 (846.804)

(3-octanoyloxy-2-undecanoyloxypropyl) (Z)-dotriacont-21-enoate

C54H102O6 (846.7676)

[2-hexadecanoyloxy-3-[(Z)-tetradec-9-enoxy]propyl] docosanoate

C55H106O5 (846.804)

[2-[(Z)-heptadec-9-enoyl]oxy-3-hexadecanoyloxypropyl] octadecanoate

C54H102O6 (846.7676)

[2-[(Z)-octadec-9-enoyl]oxy-3-tridecanoyloxypropyl] icosanoate

C54H102O6 (846.7676)

(2-pentadecanoyloxy-3-tetradecanoyloxypropyl) (Z)-docos-13-enoate

C54H102O6 (846.7676)

[1-[(Z)-icos-11-enoyl]oxy-3-undecanoyloxypropan-2-yl] icosanoate

C54H102O6 (846.7676)

(3-decanoyloxy-2-pentadecanoyloxypropyl) (Z)-hexacos-15-enoate

C54H102O6 (846.7676)

[3-dodecanoyloxy-2-[(Z)-octadec-9-enoyl]oxypropyl] henicosanoate

C54H102O6 (846.7676)

(3-dodecanoyloxy-2-tridecanoyloxypropyl) (Z)-hexacos-15-enoate

C54H102O6 (846.7676)

[2-tetradecanoyloxy-3-[(Z)-tridec-9-enoyl]oxypropyl] tetracosanoate

C54H102O6 (846.7676)

[2-[(Z)-hexadec-9-enoyl]oxy-3-undecanoyloxypropyl] tetracosanoate

C54H102O6 (846.7676)

[2-[(Z)-nonadec-9-enoyl]oxy-3-undecanoyloxypropyl] henicosanoate

C54H102O6 (846.7676)

[3-tridecanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropyl] pentacosanoate

C54H102O6 (846.7676)

[3-decanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] heptacosanoate

C54H102O6 (846.7676)

[3-tetradecanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] tricosanoate

C54H102O6 (846.7676)

[2-[(Z)-tetradec-9-enoyl]oxy-3-tridecanoyloxypropyl] tetracosanoate

C54H102O6 (846.7676)

[3-dodecanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] pentacosanoate

C54H102O6 (846.7676)

(2-hexadecanoyloxy-3-tetradecanoyloxypropyl) (Z)-henicos-11-enoate

C54H102O6 (846.7676)

(3-decanoyloxy-2-heptadecanoyloxypropyl) (Z)-tetracos-13-enoate

C54H102O6 (846.7676)

[2-[(Z)-pentadec-9-enoyl]oxy-3-tridecanoyloxypropyl] tricosanoate

C54H102O6 (846.7676)

(3-decanoyloxy-2-nonadecanoyloxypropyl) (Z)-docos-13-enoate

C54H102O6 (846.7676)

[2-[(Z)-octadec-9-enoyl]oxy-3-undecanoyloxypropyl] docosanoate

C54H102O6 (846.7676)

(2-octadecanoyloxy-3-undecanoyloxypropyl) (Z)-docos-13-enoate

C54H102O6 (846.7676)

[2-pentadecanoyloxy-3-[(Z)-tridec-9-enoyl]oxypropyl] tricosanoate

C54H102O6 (846.7676)

[2-[(Z)-heptadec-9-enoyl]oxy-3-tetradecanoyloxypropyl] icosanoate

C54H102O6 (846.7676)

[2-heptadecanoyloxy-3-[(Z)-tridec-9-enoyl]oxypropyl] henicosanoate

C54H102O6 (846.7676)

(2-tetradecanoyloxy-3-tridecanoyloxypropyl) (Z)-tetracos-13-enoate

C54H102O6 (846.7676)

[2-[(Z)-octadec-9-enoyl]oxy-3-tetradecanoyloxypropyl] nonadecanoate

C54H102O6 (846.7676)

[3-decanoyloxy-2-[(Z)-heptadec-9-enoyl]oxypropyl] tetracosanoate

C54H102O6 (846.7676)

(2-dodecanoyloxy-3-undecanoyloxypropyl) (Z)-octacos-17-enoate

C54H102O6 (846.7676)

[2-[(Z)-heptadec-9-enoyl]oxy-3-undecanoyloxypropyl] tricosanoate

C54H102O6 (846.7676)

[2-[(Z)-pentadec-9-enoyl]oxy-3-undecanoyloxypropyl] pentacosanoate

C54H102O6 (846.7676)

[3-decanoyloxy-2-[(Z)-octadec-9-enoyl]oxypropyl] tricosanoate

C54H102O6 (846.7676)

(2-tetradecanoyloxy-3-undecanoyloxypropyl) (Z)-hexacos-15-enoate

C54H102O6 (846.7676)

[2-[(Z)-tridec-9-enoyl]oxy-3-undecanoyloxypropyl] heptacosanoate

C54H102O6 (846.7676)

[3-decanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropyl] octacosanoate

C54H102O6 (846.7676)

(3-dodecanoyloxy-2-pentadecanoyloxypropyl) (Z)-tetracos-13-enoate

C54H102O6 (846.7676)

(3-decanoyloxy-2-tridecanoyloxypropyl) (Z)-octacos-17-enoate

C54H102O6 (846.7676)

(3-dodecanoyloxy-2-octadecanoyloxypropyl) (Z)-henicos-11-enoate

C54H102O6 (846.7676)

(2-hexadecanoyloxy-3-undecanoyloxypropyl) (Z)-tetracos-13-enoate

C54H102O6 (846.7676)

[3-decanoyloxy-2-[(Z)-icos-11-enoyl]oxypropyl] henicosanoate

C54H102O6 (846.7676)

[3-decanoyloxy-2-[(Z)-pentadec-9-enoyl]oxypropyl] hexacosanoate

C54H102O6 (846.7676)

(3-dodecanoyloxy-2-heptadecanoyloxypropyl) (Z)-docos-13-enoate

C54H102O6 (846.7676)

[3-dodecanoyloxy-2-[(Z)-hexadec-9-enoyl]oxypropyl] tricosanoate

C54H102O6 (846.7676)

[2-nonadecanoyloxy-3-[(Z)-tridec-9-enoyl]oxypropyl] nonadecanoate

C54H102O6 (846.7676)

(3-decanoyloxy-2-undecanoyloxypropyl) (Z)-triacont-19-enoate

C54H102O6 (846.7676)

[3-dodecanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropyl] hexacosanoate

C54H102O6 (846.7676)

[3-dodecanoyloxy-2-[(Z)-heptadec-9-enoyl]oxypropyl] docosanoate

C54H102O6 (846.7676)

(2-nonadecanoyloxy-3-undecanoyloxypropyl) (Z)-henicos-11-enoate

C54H102O6 (846.7676)

[3-decanoyloxy-2-[(Z)-nonadec-9-enoyl]oxypropyl] docosanoate

C54H102O6 (846.7676)

[3-dodecanoyloxy-2-[(Z)-pentadec-9-enoyl]oxypropyl] tetracosanoate

C54H102O6 (846.7676)

[2-[(Z)-hexadec-9-enoyl]oxy-3-tridecanoyloxypropyl] docosanoate

C54H102O6 (846.7676)

[2-hexadecanoyloxy-3-[(Z)-tridec-9-enoyl]oxypropyl] docosanoate

C54H102O6 (846.7676)

[2-[(Z)-tetradec-9-enoyl]oxy-3-undecanoyloxypropyl] hexacosanoate

C54H102O6 (846.7676)

(3-decanoyloxy-2-icosanoyloxypropyl) (Z)-henicos-11-enoate

C54H102O6 (846.7676)

[2-[(Z)-hexadec-9-enoyl]oxy-3-tetradecanoyloxypropyl] henicosanoate

C54H102O6 (846.7676)

(2-hexadecanoyloxy-3-tridecanoyloxypropyl) (Z)-docos-13-enoate

C54H102O6 (846.7676)

[3-decanoyloxy-2-[(Z)-hexadec-9-enoyl]oxypropyl] pentacosanoate

C54H102O6 (846.7676)

[2-octadecanoyloxy-3-[(Z)-tridec-9-enoyl]oxypropyl] icosanoate

C54H102O6 (846.7676)

[2-[(Z)-heptadec-9-enoyl]oxy-3-tridecanoyloxypropyl] henicosanoate

C54H102O6 (846.7676)

(2-heptadecanoyloxy-3-tridecanoyloxypropyl) (Z)-henicos-11-enoate

C54H102O6 (846.7676)

[3-hexadecanoyloxy-2-[(Z)-hexadec-9-enoyl]oxypropyl] nonadecanoate

C54H102O6 (846.7676)

[1-[(Z)-octadec-9-enoyl]oxy-3-pentadecanoyloxypropan-2-yl] octadecanoate

C54H102O6 (846.7676)

[2-heptadecanoyloxy-3-[(Z)-heptadec-9-enoyl]oxypropyl] heptadecanoate

C54H102O6 (846.7676)

[2-[(Z)-heptadec-9-enoyl]oxy-3-pentadecanoyloxypropyl] nonadecanoate

C54H102O6 (846.7676)

(2-heptadecanoyloxy-3-hexadecanoyloxypropyl) (Z)-octadec-9-enoate

C54H102O6 (846.7676)

[2-[(Z)-hexadec-9-enoyl]oxy-3-pentadecanoyloxypropyl] icosanoate

C54H102O6 (846.7676)

[2-heptadecanoyloxy-3-[(Z)-hexadec-9-enoyl]oxypropyl] octadecanoate

C54H102O6 (846.7676)

2,3-di(pentadecanoyloxy)propyl (Z)-henicos-11-enoate

C54H102O6 (846.7676)

[2-[(Z)-hexacos-15-enoyl]oxy-3-hydroxypropyl] hexacosanoate

C55H106O5 (846.804)

2,3-di(hexadecanoyloxy)propyl (Z)-nonadec-9-enoate

C54H102O6 (846.7676)

[1-[(Z)-nonadec-9-enoyl]oxy-3-tridecanoyloxypropan-2-yl] nonadecanoate

C54H102O6 (846.7676)

(2-heptadecanoyloxy-3-tetradecanoyloxypropyl) (Z)-icos-11-enoate

C54H102O6 (846.7676)

[2-pentadecanoyloxy-3-[(Z)-tetradec-9-enoyl]oxypropyl] docosanoate

C54H102O6 (846.7676)

[2-hexadecanoyloxy-3-[(Z)-pentadec-9-enoyl]oxypropyl] icosanoate

C54H102O6 (846.7676)

[2-octadecanoyloxy-3-[(Z)-tetradec-9-enoyl]oxypropyl] nonadecanoate

C54H102O6 (846.7676)

[2-[(Z)-pentadec-9-enoyl]oxy-3-tetradecanoyloxypropyl] docosanoate

C54H102O6 (846.7676)

[3-dodecanoyloxy-2-[(Z)-nonadec-9-enoyl]oxypropyl] icosanoate

C54H102O6 (846.7676)

[2-heptadecanoyloxy-3-[(Z)-pentadec-9-enoyl]oxypropyl] nonadecanoate

C54H102O6 (846.7676)

[2-octadecanoyloxy-3-[(Z)-pentadec-9-enoyl]oxypropyl] octadecanoate

C54H102O6 (846.7676)

(2-octadecanoyloxy-3-tridecanoyloxypropyl) (Z)-icos-11-enoate

C54H102O6 (846.7676)

(2-octadecanoyloxy-3-tetradecanoyloxypropyl) (Z)-nonadec-9-enoate

C54H102O6 (846.7676)

[2-heptadecanoyloxy-3-[(Z)-tetradec-9-enoyl]oxypropyl] icosanoate

C54H102O6 (846.7676)

(2-hexadecanoyloxy-3-pentadecanoyloxypropyl) (Z)-icos-11-enoate

C54H102O6 (846.7676)

(2-heptadecanoyloxy-3-pentadecanoyloxypropyl) (Z)-nonadec-9-enoate

C54H102O6 (846.7676)

[2-hexadecanoyloxy-3-[(Z)-tetradec-9-enoyl]oxypropyl] henicosanoate

C54H102O6 (846.7676)

[3-pentadecanoyloxy-2-[(Z)-pentadec-9-enoyl]oxypropyl] henicosanoate

C54H102O6 (846.7676)

(3-dodecanoyloxy-2-nonadecanoyloxypropyl) (Z)-icos-11-enoate

C54H102O6 (846.7676)

[2-nonadecanoyloxy-3-[(Z)-tridec-8-enoyl]oxypropyl] nonadecanoate

C54H102O6 (846.7676)

(3-dodecanoyloxy-2-octadecanoyloxypropyl) (Z)-henicos-9-enoate

C54H102O6 (846.7676)

(2-heptadecanoyloxy-3-hexadecanoyloxypropyl) (Z)-octadec-11-enoate

C54H102O6 (846.7676)

(2-heptadecanoyloxy-3-tridecanoyloxypropyl) (Z)-henicos-9-enoate

C54H102O6 (846.7676)

[2-[(Z)-octadec-11-enoyl]oxy-3-tridecanoyloxypropyl] icosanoate

C54H102O6 (846.7676)

(2-pentadecanoyloxy-3-tetradecanoyloxypropyl) (Z)-docos-11-enoate

C54H102O6 (846.7676)

[2-[(Z)-hexadec-7-enoyl]oxy-3-tetradecanoyloxypropyl] henicosanoate

C54H102O6 (846.7676)

[2-[(Z)-hexadec-7-enoyl]oxy-3-tridecanoyloxypropyl] docosanoate

C54H102O6 (846.7676)

[2-hexadecanoyloxy-3-[(Z)-tridec-8-enoyl]oxypropyl] docosanoate

C54H102O6 (846.7676)

[2-heptadecanoyloxy-3-[(Z)-tridec-8-enoyl]oxypropyl] henicosanoate

C54H102O6 (846.7676)

[3-[(Z)-dodec-5-enoyl]oxy-2-octadecanoyloxypropyl] henicosanoate

C54H102O6 (846.7676)

[3-dodecanoyloxy-2-[(Z)-octadec-11-enoyl]oxypropyl] henicosanoate

C54H102O6 (846.7676)

[2-[(Z)-heptadec-7-enoyl]oxy-3-hexadecanoyloxypropyl] octadecanoate

C54H102O6 (846.7676)

[2-[(Z)-heptadec-7-enoyl]oxy-3-tridecanoyloxypropyl] henicosanoate

C54H102O6 (846.7676)

[1-[(Z)-octadec-11-enoyl]oxy-3-pentadecanoyloxypropan-2-yl] octadecanoate

C54H102O6 (846.7676)

[2-[(Z)-octadec-11-enoyl]oxy-3-tetradecanoyloxypropyl] nonadecanoate

C54H102O6 (846.7676)

[2-heptadecanoyloxy-3-[(Z)-heptadec-7-enoyl]oxypropyl] heptadecanoate

C54H102O6 (846.7676)

[2-[(Z)-heptadec-7-enoyl]oxy-3-pentadecanoyloxypropyl] nonadecanoate

C54H102O6 (846.7676)

[3-dodecanoyloxy-2-[(Z)-heptadec-7-enoyl]oxypropyl] docosanoate

C54H102O6 (846.7676)

2,3-di(pentadecanoyloxy)propyl (Z)-henicos-9-enoate

C54H102O6 (846.7676)

[3-[(Z)-dodec-5-enoyl]oxy-2-nonadecanoyloxypropyl] icosanoate

C54H102O6 (846.7676)

[3-[(Z)-dodec-5-enoyl]oxy-2-heptadecanoyloxypropyl] docosanoate

C54H102O6 (846.7676)

(2-hexadecanoyloxy-3-tridecanoyloxypropyl) (Z)-docos-11-enoate

C54H102O6 (846.7676)

[2-heptadecanoyloxy-3-[(Z)-hexadec-7-enoyl]oxypropyl] octadecanoate

C54H102O6 (846.7676)

[2-[(Z)-heptadec-7-enoyl]oxy-3-tetradecanoyloxypropyl] icosanoate

C54H102O6 (846.7676)

[2-octadecanoyloxy-3-[(Z)-tridec-8-enoyl]oxypropyl] icosanoate

C54H102O6 (846.7676)

[3-hexadecanoyloxy-2-[(Z)-hexadec-7-enoyl]oxypropyl] nonadecanoate

C54H102O6 (846.7676)

[2-[(Z)-hexadec-7-enoyl]oxy-3-pentadecanoyloxypropyl] icosanoate

C54H102O6 (846.7676)

(2-hexadecanoyloxy-3-tetradecanoyloxypropyl) (Z)-henicos-9-enoate

C54H102O6 (846.7676)

(3-dodecanoyloxy-2-heptadecanoyloxypropyl) (Z)-docos-11-enoate

C54H102O6 (846.7676)

2-[(2-Henicosanoyloxy-3-icosoxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C49H101NO7P+ (846.7315)

2-[(2-Docosanoyloxy-3-nonadecoxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C49H101NO7P+ (846.7315)

[1-carboxy-3-[3-[(10E,13E,16E)-nonadeca-10,13,16-trienoyl]oxy-2-tricosanoyloxypropoxy]propyl]-trimethylazanium

C52H96NO7+ (846.7186)

[1-carboxy-3-[2-[(10E,12E)-octadeca-10,12-dienoyl]oxy-3-[(E)-tetracos-11-enoyl]oxypropoxy]propyl]-trimethylazanium

C52H96NO7+ (846.7186)

[1-carboxy-3-[3-henicosanoyloxy-2-[(9E,11E,13E)-henicosa-9,11,13-trienoyl]oxypropoxy]propyl]-trimethylazanium

C52H96NO7+ (846.7186)

[1-carboxy-3-[2-[(E)-octadec-11-enoyl]oxy-3-[(18E,21E)-tetracosa-18,21-dienoyl]oxypropoxy]propyl]-trimethylazanium

C52H96NO7+ (846.7186)

[1-carboxy-3-[3-hexacosanoyloxy-2-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxypropoxy]propyl]-trimethylazanium

C52H96NO7+ (846.7186)

[1-carboxy-3-[3-heptadecanoyloxy-2-[(13E,16E,19E)-pentacosa-13,16,19-trienoyl]oxypropoxy]propyl]-trimethylazanium

C52H96NO7+ (846.7186)

[1-carboxy-3-[2-[(E)-docos-11-enoyl]oxy-3-[(11E,14E)-icosa-11,14-dienoyl]oxypropoxy]propyl]-trimethylazanium

C52H96NO7+ (846.7186)

[1-carboxy-3-[2-[(7E,9E)-nonadeca-7,9-dienoyl]oxy-3-[(E)-tricos-11-enoyl]oxypropoxy]propyl]-trimethylazanium

C52H96NO7+ (846.7186)

[(2R)-2-[(E)-heptadec-9-enoyl]oxy-3-hexadecanoyloxypropyl] octadecanoate

C54H102O6 (846.7676)

[(2R)-2-heptadecanoyloxy-3-hexadecanoyloxypropyl] (E)-octadec-11-enoate

C54H102O6 (846.7676)

[1-carboxy-3-[2-[(11E,13E,15E)-octadeca-11,13,15-trienoyl]oxy-3-tetracosanoyloxypropoxy]propyl]-trimethylazanium

C52H96NO7+ (846.7186)

[1-carboxy-3-[2-nonadecanoyloxy-3-[(14E,17E,20E)-tricosa-14,17,20-trienoyl]oxypropoxy]propyl]-trimethylazanium

C52H96NO7+ (846.7186)

[(2R)-3-hexadecanoyloxy-2-[(E)-hexadec-9-enoyl]oxypropyl] nonadecanoate

C54H102O6 (846.7676)

[1-carboxy-3-[3-octadecanoyloxy-2-[(15E,18E,21E)-tetracosa-15,18,21-trienoyl]oxypropoxy]propyl]-trimethylazanium

C52H96NO7+ (846.7186)

[1-carboxy-3-[3-[(11E,13E,15E)-octadeca-11,13,15-trienoyl]oxy-2-tetracosanoyloxypropoxy]propyl]-trimethylazanium

C52H96NO7+ (846.7186)

[1-carboxy-3-[3-[(8E,11E,14E)-heptadeca-8,11,14-trienoyl]oxy-2-pentacosanoyloxypropoxy]propyl]-trimethylazanium

C52H96NO7+ (846.7186)

[1-carboxy-3-[2-[(E)-nonadec-9-enoyl]oxy-3-[(14E,16E)-tricosa-14,16-dienoyl]oxypropoxy]propyl]-trimethylazanium

C52H96NO7+ (846.7186)

[1-carboxy-3-[3-[(E)-octadec-11-enoyl]oxy-2-[(18E,21E)-tetracosa-18,21-dienoyl]oxypropoxy]propyl]-trimethylazanium

C52H96NO7+ (846.7186)

[1-carboxy-3-[2-[(9E,11E)-henicosa-9,11-dienoyl]oxy-3-[(E)-henicos-9-enoyl]oxypropoxy]propyl]-trimethylazanium

C52H96NO7+ (846.7186)

[1-carboxy-3-[3-[(11E,14E)-heptadeca-11,14-dienoyl]oxy-2-[(E)-pentacos-11-enoyl]oxypropoxy]propyl]-trimethylazanium

C52H96NO7+ (846.7186)

[1-carboxy-3-[3-[(11E,14E)-hexacosa-11,14-dienoyl]oxy-2-[(E)-hexadec-7-enoyl]oxypropoxy]propyl]-trimethylazanium

C52H96NO7+ (846.7186)

[1-carboxy-3-[2-[(11E,14E)-heptadeca-11,14-dienoyl]oxy-3-[(E)-pentacos-11-enoyl]oxypropoxy]propyl]-trimethylazanium

C52H96NO7+ (846.7186)

[1-carboxy-3-[3-[(17E,20E,23E)-hexacosa-17,20,23-trienoyl]oxy-2-hexadecanoyloxypropoxy]propyl]-trimethylazanium

C52H96NO7+ (846.7186)

[1-carboxy-3-[2-[(8E,11E,14E)-heptadeca-8,11,14-trienoyl]oxy-3-pentacosanoyloxypropoxy]propyl]-trimethylazanium

C52H96NO7+ (846.7186)

[1-carboxy-3-[2-hexacosanoyloxy-3-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxypropoxy]propyl]-trimethylazanium

C52H96NO7+ (846.7186)

[(2R)-2-heptadecanoyloxy-3-[(E)-heptadec-9-enoyl]oxypropyl] heptadecanoate

C54H102O6 (846.7676)

[3-heptadecanoyloxy-2-[(E)-heptadec-9-enoyl]oxypropyl] heptadecanoate

C54H102O6 (846.7676)

[1-carboxy-3-[3-[(E)-hexacos-11-enoyl]oxy-2-[(4E,7E)-hexadeca-4,7-dienoyl]oxypropoxy]propyl]-trimethylazanium

C52H96NO7+ (846.7186)

[1-carboxy-3-[3-[(14E,16E)-docosa-14,16-dienoyl]oxy-2-[(E)-icos-11-enoyl]oxypropoxy]propyl]-trimethylazanium

C52H96NO7+ (846.7186)

[1-carboxy-3-[3-[(9E,11E)-henicosa-9,11-dienoyl]oxy-2-[(E)-henicos-9-enoyl]oxypropoxy]propyl]-trimethylazanium

C52H96NO7+ (846.7186)

[1-carboxy-3-[2-octadecanoyloxy-3-[(15E,18E,21E)-tetracosa-15,18,21-trienoyl]oxypropoxy]propyl]-trimethylazanium

C52H96NO7+ (846.7186)

[1-carboxy-3-[3-[(E)-heptadec-7-enoyl]oxy-2-[(11E,14E)-pentacosa-11,14-dienoyl]oxypropoxy]propyl]-trimethylazanium

C52H96NO7+ (846.7186)

[1-carboxy-3-[3-[(13E,16E,19E)-docosa-13,16,19-trienoyl]oxy-2-icosanoyloxypropoxy]propyl]-trimethylazanium

C52H96NO7+ (846.7186)

[1-carboxy-3-[2-heptadecanoyloxy-3-[(13E,16E,19E)-pentacosa-13,16,19-trienoyl]oxypropoxy]propyl]-trimethylazanium

C52H96NO7+ (846.7186)

[1-carboxy-3-[3-[(7E,9E)-nonadeca-7,9-dienoyl]oxy-2-[(E)-tricos-11-enoyl]oxypropoxy]propyl]-trimethylazanium

C52H96NO7+ (846.7186)

[1-carboxy-3-[3-[(10E,12E)-octadeca-10,12-dienoyl]oxy-2-[(E)-tetracos-11-enoyl]oxypropoxy]propyl]-trimethylazanium

C52H96NO7+ (846.7186)

[(2S)-1-[(E)-hexacos-5-enoyl]oxy-3-hydroxypropan-2-yl] hexacosanoate

C55H106O5 (846.804)

[1-carboxy-3-[3-[(E)-docos-11-enoyl]oxy-2-[(11E,14E)-icosa-11,14-dienoyl]oxypropoxy]propyl]-trimethylazanium

C52H96NO7+ (846.7186)

[(2S)-2-heptadecanoyloxy-3-[(E)-hexadec-9-enoyl]oxypropyl] octadecanoate

C54H102O6 (846.7676)

[1-carboxy-3-[2-[(14E,16E)-docosa-14,16-dienoyl]oxy-3-[(E)-icos-11-enoyl]oxypropoxy]propyl]-trimethylazanium

C52H96NO7+ (846.7186)

[1-carboxy-3-[2-[(11E,14E)-hexacosa-11,14-dienoyl]oxy-3-[(E)-hexadec-7-enoyl]oxypropoxy]propyl]-trimethylazanium

C52H96NO7+ (846.7186)

[1-carboxy-3-[3-[(E)-nonadec-9-enoyl]oxy-2-[(14E,16E)-tricosa-14,16-dienoyl]oxypropoxy]propyl]-trimethylazanium

C52H96NO7+ (846.7186)

[1-carboxy-3-[2-[(17E,20E,23E)-hexacosa-17,20,23-trienoyl]oxy-3-hexadecanoyloxypropoxy]propyl]-trimethylazanium

C52H96NO7+ (846.7186)

[1-carboxy-3-[3-nonadecanoyloxy-2-[(14E,17E,20E)-tricosa-14,17,20-trienoyl]oxypropoxy]propyl]-trimethylazanium

C52H96NO7+ (846.7186)

[1-carboxy-3-[2-henicosanoyloxy-3-[(9E,11E,13E)-henicosa-9,11,13-trienoyl]oxypropoxy]propyl]-trimethylazanium

C52H96NO7+ (846.7186)

[(2S)-2-[(E)-hexacos-5-enoyl]oxy-3-hydroxypropyl] hexacosanoate

C55H106O5 (846.804)

[1-carboxy-3-[2-[(13E,16E,19E)-docosa-13,16,19-trienoyl]oxy-3-icosanoyloxypropoxy]propyl]-trimethylazanium

C52H96NO7+ (846.7186)

[1-carboxy-3-[2-[(E)-hexacos-11-enoyl]oxy-3-[(4E,7E)-hexadeca-4,7-dienoyl]oxypropoxy]propyl]-trimethylazanium

C52H96NO7+ (846.7186)

[1-carboxy-3-[2-[(E)-heptadec-7-enoyl]oxy-3-[(11E,14E)-pentacosa-11,14-dienoyl]oxypropoxy]propyl]-trimethylazanium

C52H96NO7+ (846.7186)

[1-carboxy-3-[2-docosanoyloxy-3-[(5E,8E,11E)-icosa-5,8,11-trienoyl]oxypropoxy]propyl]-trimethylazanium

C52H96NO7+ (846.7186)

[1-carboxy-3-[2-[(10E,13E,16E)-nonadeca-10,13,16-trienoyl]oxy-3-tricosanoyloxypropoxy]propyl]-trimethylazanium

C52H96NO7+ (846.7186)

[1-carboxy-3-[3-docosanoyloxy-2-[(5E,8E,11E)-icosa-5,8,11-trienoyl]oxypropoxy]propyl]-trimethylazanium

C52H96NO7+ (846.7186)

[1-carboxy-3-[3-[(Z)-hexacos-15-enoyl]oxy-2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxypropoxy]propyl]-trimethylazanium

C52H96NO7+ (846.7186)

[1-carboxy-3-[2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxy-3-[(Z)-tetracos-13-enoyl]oxypropoxy]propyl]-trimethylazanium

C52H96NO7+ (846.7186)

[1-carboxy-3-[2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-3-[(Z)-henicos-11-enoyl]oxypropoxy]propyl]-trimethylazanium

C52H96NO7+ (846.7186)

[1-carboxy-3-[3-[(Z)-docos-13-enoyl]oxy-2-[(11Z,14Z)-icosa-11,14-dienoyl]oxypropoxy]propyl]-trimethylazanium

C52H96NO7+ (846.7186)

[1-carboxy-3-[3-docosanoyloxy-2-[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]oxypropoxy]propyl]-trimethylazanium

C52H96NO7+ (846.7186)

[1-carboxy-3-[2-[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]oxy-3-icosanoyloxypropoxy]propyl]-trimethylazanium

C52H96NO7+ (846.7186)

2-[(2-Heptacosanoyloxy-3-tetradecoxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C49H101NO7P+ (846.7315)

[1-carboxy-3-[2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxy-3-tetracosanoyloxypropoxy]propyl]-trimethylazanium

C52H96NO7+ (846.7186)

[1-carboxy-3-[2-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-3-[(Z)-icos-11-enoyl]oxypropoxy]propyl]-trimethylazanium

C52H96NO7+ (846.7186)

2-[(3-Hexadecoxy-2-pentacosanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C49H101NO7P+ (846.7315)

2-[Hydroxy-(3-octadecoxy-2-tricosanoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium

C49H101NO7P+ (846.7315)

[1-carboxy-3-[3-hexacosanoyloxy-2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxypropoxy]propyl]-trimethylazanium

C52H96NO7+ (846.7186)

[1-carboxy-3-[2-[(15Z,18Z)-hexacosa-15,18-dienoyl]oxy-3-[(Z)-hexadec-9-enoyl]oxypropoxy]propyl]-trimethylazanium

C52H96NO7+ (846.7186)

[1-carboxy-3-[3-[(Z)-octadec-9-enoyl]oxy-2-[(13Z,16Z)-tetracosa-13,16-dienoyl]oxypropoxy]propyl]-trimethylazanium

C52H96NO7+ (846.7186)

2-[Hydroxy-(2-octacosanoyloxy-3-tridecoxypropoxy)phosphoryl]oxyethyl-trimethylazanium

C49H101NO7P+ (846.7315)

2-[(3-Hentetracontanoyloxy-2-hydroxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C49H101NO7P+ (846.7315)

2-[(2-Hexacosanoyloxy-3-pentadecoxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C49H101NO7P+ (846.7315)

2-[Hydroxy-(2-octadecanoyloxy-3-tricosoxypropoxy)phosphoryl]oxyethyl-trimethylazanium

C49H101NO7P+ (846.7315)

2-[(3-Heptacosoxy-2-tetradecanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C49H101NO7P+ (846.7315)

2-[(2-Heptadecanoyloxy-3-tetracosoxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C49H101NO7P+ (846.7315)

2-[(3-Docosoxy-2-nonadecanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C49H101NO7P+ (846.7315)

2-[(3-Henicosoxy-2-icosanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C49H101NO7P+ (846.7315)

2-[(2-Hexadecanoyloxy-3-pentacosoxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C49H101NO7P+ (846.7315)

2-[Hydroxy-(3-octacosoxy-2-tridecanoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium

C49H101NO7P+ (846.7315)

2-[(3-Hexacosoxy-2-pentadecanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C49H101NO7P+ (846.7315)

2-[(3-Heptadecoxy-2-tetracosanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C49H101NO7P+ (846.7315)

1-Stearoyl-2-stearyl-3-palmitoleoyl-glycerol

C55H106O5 (846.804)

triacylglycerol 51:1

C54H102O6 (846.7676)

A triglyceride in which the three acyl groups contain a total of 51 carbons and 1 double bond.

DG(52:1)

C55H106O5 (846.804)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

NA-Orn 48:1

C53H102N2O5 (846.7788)

FAHFA 57:7;O

C57H98O4 (846.7465)

DG 14:1_38:0

C55H106O5 (846.804)

DG 15:1_37:0

C55H106O5 (846.804)

DG 16:1_36:0

C55H106O5 (846.804)

DG 17:1_35:0

C55H106O5 (846.804)

DG 18:1_34:0

C55H106O5 (846.804)

DG 20:1_32:0

C55H106O5 (846.804)

DG 22:1_30:0

C55H106O5 (846.804)

DG 24:1_28:0

C55H106O5 (846.804)

DG 26:0_26:1

C55H106O5 (846.804)

DG 52:1

C55H106O5 (846.804)

TG O-52:1

C55H106O5 (846.804)

TG P-52:1

C55H106O5 (846.804)

MeDAG 52:1

C55H106O5 (846.804)

TG O-18:0_16:0_18:1

C55H106O5 (846.804)

TG 10:0_14:1_27:0

C54H102O6 (846.7676)

TG 10:0_15:0_26:1

C54H102O6 (846.7676)

TG 10:0_15:1_26:0

C54H102O6 (846.7676)

TG 10:0_16:1_25:0

C54H102O6 (846.7676)

TG 10:0_17:0_24:1

C54H102O6 (846.7676)

TG 10:0_17:1_24:0

C54H102O6 (846.7676)

TG 10:0_18:1_23:0

C54H102O6 (846.7676)

TG 10:0_19:0_22:1

C54H102O6 (846.7676)

TG 10:0_20:1_21:0

C54H102O6 (846.7676)

TG 11:0_14:0_26:1

C54H102O6 (846.7676)

TG 11:0_14:1_26:0

C54H102O6 (846.7676)

TG 11:0_15:1_25:0

C54H102O6 (846.7676)

TG 11:0_16:0_24:1

C54H102O6 (846.7676)

TG 11:0_16:1_24:0

C54H102O6 (846.7676)

TG 11:0_17:1_23:0

C54H102O6 (846.7676)

TG 11:0_18:0_22:1

C54H102O6 (846.7676)

TG 11:0_18:1_22:0

C54H102O6 (846.7676)

TG 11:0_20:0_20:1

C54H102O6 (846.7676)

TG 12:0_13:0_26:1

C54H102O6 (846.7676)

TG 12:0_14:1_25:0

C54H102O6 (846.7676)

TG 12:0_15:0_24:1

C54H102O6 (846.7676)

TG 12:0_15:1_24:0

C54H102O6 (846.7676)

TG 12:0_16:1_23:0

C54H102O6 (846.7676)

TG 12:0_17:0_22:1

C54H102O6 (846.7676)

TG 12:0_17:1_22:0

C54H102O6 (846.7676)

TG 12:0_18:1_21:0

C54H102O6 (846.7676)

TG 12:0_19:0_20:1

C54H102O6 (846.7676)

TG 13:0_14:0_24:1

C54H102O6 (846.7676)

TG 13:0_14:1_24:0

C54H102O6 (846.7676)

TG 13:0_15:1_23:0

C54H102O6 (846.7676)

TG 13:0_16:0_22:1

C54H102O6 (846.7676)

TG 13:0_16:1_22:0

C54H102O6 (846.7676)

TG 13:0_17:1_21:0

C54H102O6 (846.7676)

TG 13:0_18:0_20:1

C54H102O6 (846.7676)

TG 13:0_18:1_20:0

C54H102O6 (846.7676)

TG 14:0_14:1_23:0

C54H102O6 (846.7676)

TG 14:0_15:0_22:1

C54H102O6 (846.7676)

TG 14:0_15:1_22:0

C54H102O6 (846.7676)

TG 14:0_16:1_21:0

C54H102O6 (846.7676)

TG 14:0_17:0_20:1

C54H102O6 (846.7676)

TG 14:0_17:1_20:0

C54H102O6 (846.7676)

TG 14:0_18:1_19:0

C54H102O6 (846.7676)

TG 14:1_15:0_22:0

C54H102O6 (846.7676)

TG 14:1_16:0_21:0

C54H102O6 (846.7676)

TG 14:1_17:0_20:0

C54H102O6 (846.7676)

TG 14:1_18:0_19:0

C54H102O6 (846.7676)

TG 15:0_15:1_21:0

C54H102O6 (846.7676)

TG 15:0_16:0_20:1

C54H102O6 (846.7676)

TG 15:0_16:1_20:0

C54H102O6 (846.7676)

TG 15:0_17:1_19:0

C54H102O6 (846.7676)

TG 15:0_18:0_18:1

C54H102O6 (846.7676)

TG 15:1_16:0_20:0

C54H102O6 (846.7676)

TG 15:1_17:0_19:0

C54H102O6 (846.7676)

TG 15:1_18:0_18:0

C54H102O6 (846.7676)

TG 16:0_16:0_19:1

C54H102O6 (846.7676)

TG 16:0_16:1_19:0

C54H102O6 (846.7676)

TG 16:0_17:0_18:1

C54H102O6 (846.7676)

TG 16:0/17:0/18:1

C54H102O6 (846.7676)

TG 16:0_17:1_18:0

C54H102O6 (846.7676)

TG 16:1_17:0_18:0

C54H102O6 (846.7676)

TG 17:0_17:0_17:1

C54H102O6 (846.7676)

TG 51:1_12:0

C54H102O6 (846.7676)

TG 51:1_14:0

C54H102O6 (846.7676)

TG 51:1_14:1

C54H102O6 (846.7676)

TG 51:1_15:0

C54H102O6 (846.7676)

TG 51:1_16:0

C54H102O6 (846.7676)

TG 51:1_16:1

C54H102O6 (846.7676)

TG 51:1_17:0

C54H102O6 (846.7676)

TG 51:1_18:0

C54H102O6 (846.7676)

TG 51:1_18:1

C54H102O6 (846.7676)

TG 51:1_20:0

C54H102O6 (846.7676)

TG 51:1_20:1

C54H102O6 (846.7676)

TG 51:1_22:1

C54H102O6 (846.7676)

CerPE 20:0;O2/26:0;O

C48H99N2O7P (846.719)

CerPE 21:0;O2/25:0;O

C48H99N2O7P (846.719)

CerPE 22:0;O2/24:0;O

C48H99N2O7P (846.719)

CerPE 46:0;O2;O

C48H99N2O7P (846.719)

SM 17:0;O2/26:0;O

C48H99N2O7P (846.719)

SM 18:0;O2/25:0;O

C48H99N2O7P (846.719)

SM 19:0;O2/24:0;O

C48H99N2O7P (846.719)

SM 20:0;O2/23:0;O

C48H99N2O7P (846.719)